Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401
Iwama, Eiji, Goto, Yasushi, Murakami, Haruyasu, Tsumura, Shinsuke, Sakashita, Hiroyuki, Mori, Yoshiaki, Nakagaki, Noriaki, Fujita, Yuka, Seike, Masahiro, Bessho, Akihiro, Ono, Manabu, Nishitsuji, MasaJournal:
The Oncologist
DOI:
10.1634/theoncologist.2019-0728
Date:
October, 2019
File:
PDF, 894 KB
2019